The U.S. Food and Drug Administration on Thursday approves Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase.

The FDA says its decision will give American consumers an additional, lower cost alternative when choosing prescription drug products.

Dr. Steven Galson, Director of FDA's Center for Drug Evaluation and Research says, "Except for their price, which is much lower, generic drugs are in every way equivalent to their brand name counterparts."

He adds, "Offering consumers a choice of safe, effective, and reasonably priced generic drug products is an extremely important priority for FDA. Today's approval is part of our ongoing commitment to provide generic forms of products to the public."

The FDA's Office of Generic Drugs approved 452 generic drug applications in 2005, the second highest total on record.

Fluticasone Propionate Nasal Spray treats the nasal symptoms of seasonal and chronic (long-lasting) allergic and nonallergic rhinitis, an inflammation of the lining of the nose that can make it stuffy and runny. This product is approved for use in both adults and children 4-years and older.